NCT04551170View on ClinicalTrials.gov

Theophylline Treatment for Pseudohypoparathyroidism - Children 2-12 Years Old

PHASE2RecruitingINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

July 13, 2020

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
PseudohypoparathyroidismAlbright Hereditary OsteodystrophyPseudohypoparathyroidism Type 1a
Interventions
DRUG

Theophylline

oral theophylline

DRUG

Placebo

Placebo capsule or elixir

Trial Locations (1)

37212

RECRUITING

Vanderbilt University Medical Center, Nashville

All Listed Sponsors
lead

Vanderbilt University Medical Center

OTHER